{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:33:22Z","timestamp":1790804002891,"version":"4.1.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.autrev.2015.07.002","type":"journal-article","created":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T01:24:24Z","timestamp":1436318664000},"page":"1019-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Anti-SSA\/SSB-negative Sj\u00f6gren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution"],"prefix":"10.1016","volume":"14","author":[{"given":"Luca","family":"Quartuccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Baldini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Priori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Alunno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Colafrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Luciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Gerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guido","family":"Valesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Bombardieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1-2","key":"10.1016\/j.autrev.2015.07.002_bb0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jaut.2012.01.002","article-title":"Pathogenesis of Sj\u00f6gren's syndrome: what we know and what we should learn","volume":"39","author":"Tzioufas","year":"2012","journal-title":"J Autoimmun"},{"issue":"5","key":"10.1016\/j.autrev.2015.07.002_bb0010","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1093\/rheumatology\/ket427","article-title":"Primary Sjogren's syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients","volume":"53","author":"Baldini","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2015.07.002_bb0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/ket349","volume":"53","author":"Ramos-Casals","year":"2014","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.002_bb0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.autrev.2014.02.002","article-title":"Genome-wide association studies in Sj\u00f6gren's syndrome: what do the genes tell us about disease pathogenesis?","volume":"13","author":"Burbelo","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.002_bb0025","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.autrev.2015.03.008","article-title":"Google-driven search for big data in autoimmune geoepidemiology: analysis of 394,827 patients with systemic autoimmune diseases","volume":"14","author":"Ramos-Casals","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.002_bb0030","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"European Study Group on Classification Criteria for Sj\u00f6gren's Syndrome. Classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American\u2013European Consensus Group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.07.002_bb0035","author":"Brito-Zer\u00f3n","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2015.07.002_bb0040","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1136\/ard.2004.030643","article-title":"Correlation of serum B lymphocyte stimulator and beta2 microglobulin with autoantibody secretion and systemic involvement in primary Sj\u00f6gren's syndrome","volume":"64","author":"Gottenberg","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0045","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1177\/0961203314554251","article-title":"A retrospective, multicenter study evaluating the prognostic value of minor salivary gland histology in a large cohort of patients with primary Sj\u00f6gren's syndrome","volume":"24","author":"Carubbi","year":"2015","journal-title":"Lupus"},{"issue":"1","key":"10.1016\/j.autrev.2015.07.002_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3109\/03009742.2014.923931","article-title":"Clinical and biological differences between cryoglobulinaemic and hypergammaglobulinaemic purpura in primary Sj\u00f6gren's syndrome: results of a large multicentre study","volume":"44","author":"Quartuccio","year":"2015","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2015.07.002_bb0055","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.jaut.2013.10.002","article-title":"Biomarkers of lymphoma in Sj\u00f6gren's syndrome and evaluation of the lymphoma risk in prelymphomatous conditions: results of a multicenter study","volume":"51","author":"Quartuccio","year":"2014","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.002_bb0060","doi-asserted-by":"crossref","first-page":"4029","DOI":"10.1182\/blood-2007-10-119974","article-title":"Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium","volume":"111","author":"Ekstr\u00f6m Smedby","year":"2008","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.002_bb0065","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1586\/1744666X.2014.872986","article-title":"Predicting progression to lymphoma in Sj\u00f6gren's syndrome patients","volume":"10","author":"Giannouli","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0070","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/bjh.13192","article-title":"Sj\u00f6gren syndrome-associated lymphomas: an update on pathogenesis and management","volume":"168","author":"Nocturne","year":"2015","journal-title":"Br J Haematol"},{"issue":"9 Pt 2","key":"10.1016\/j.autrev.2015.07.002_bb0075","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1016\/j.lpm.2012.05.025","article-title":"Predictors for the development of non-Hodgkin lymphoma in primary Sj\u00f6gren's syndrome","volume":"41","author":"Jonsson","year":"2012","journal-title":"Presse Med"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.002_bb0080","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.rdc.2008.08.006","article-title":"Mucosa-associatedlymphoidtissuelymphoma in Sj\u00f6gren's syndrome: risks, management, and prognosis","volume":"34","author":"Voulgarelis","year":"2008","journal-title":"Rheum Dis Clin North Am"},{"issue":"8","key":"10.1016\/j.autrev.2015.07.002_bb0085","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/ard.2010.144782","article-title":"Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sj\u00f6gren's syndrome","volume":"70","author":"Theander","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0090","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sj\u00f6gren\u05f3s syndrome? Association between clinical, histopathological, and molecular features: a retrospective study","volume":"44","author":"Carubbi","year":"2014","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0095","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/1521-4141(200203)32:3<903::AID-IMMU903>3.0.CO;2-D","article-title":"Salivary gland B cell lymphoproliferative disorders in Sj\u00f6gren's syndrome present a restricted use of antigen receptor gene segments similar to those used by hepatitis C virus-associated non-Hodgkins's lymphomas","volume":"32","author":"De Re","year":"2002","journal-title":"Eur J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0100","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1191\/096120398678920019","article-title":"Young onset of primary Sj\u00f6gren's syndrome: clinical and immunological characteristics","volume":"7","author":"Ramos-Casals","year":"1998","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.002_bb0105","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/03009749950155599","article-title":"The influence of age on disease manifestations and serological characteristics in primary Sj\u00f6gren's syndrome","volume":"28","author":"Haga","year":"1999","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.autrev.2015.07.002_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/art.39231","article-title":"A B-cell activating factor receptor (BAFF-R) His159Tyr mutation in Sj\u00f6gren's Syndrome related lymphoproliferation","author":"Papageorgiou","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2015.07.002_bb0115","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/annrheumdis-2012-202293","article-title":"Club Rhumatismeset Inflammations and the French Society of Rheumatology. Efficacy of rituximab in systemic manifestations of primary Sj\u00f6gren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry","volume":"72","author":"Gottenberg","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2015.07.002_bb0120","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/M13-1085","article-title":"Treatment of primary Sj\u00f6gren syndrome with rituximab: a randomized trial","volume":"160","author":"Devauchelle-Pensec","year":"2014","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.autrev.2015.07.002_bb0125","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1136\/annrheumdis-2013-203991","article-title":"Efficacy and safety of belimumab in primary Sj\u00f6gren's syndrome: results of the BELISS open-label phase II study","volume":"74","author":"Mariette","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl2","key":"10.1016\/j.autrev.2015.07.002_bb0130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1136\/annrheumdis-2015-eular.3101","article-title":"Efficacy and safety of belimumab given for 12 months in primary Sj\u00f6gren's syndrome: the beliss open-label phase II study","volume":"74","author":"De Vita","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.autrev.2015.07.002_bb0135","first-page":"102","article-title":"Big Data Sj\u00f6gren Project (EULAR-SS Task Force International Network): characterization t diagnosis of 5027 patients with primary Sj\u00f6gren syndrome","volume":"74","author":"Brito Zeron","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215001512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215001512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T22:37:54Z","timestamp":1748471874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215001512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S1568997215001512"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.07.002","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-SSA\/SSB-negative Sj\u00f6gren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}